2025. Severe Hyponatremia with Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials. Open Access Indonesian Journal of Medical Reviews. 6, 1 (Nov. 2025), 35–50. DOI:https://doi.org/10.37275/oaijmr.v6i1.826.